Head to Head Analysis: Lucira Health (LHDXQ) & Its Rivals
Head to Head Analysis: Lucira Health (LHDXQ) & Its Rivals
Lucira Health (NASDAQ:LHDXQ – Get Rating) is one of 41 public companies in the "Diagnostic substances" industry, but how does it weigh in compared to its competitors? We will compare Lucira Health to related businesses based on the strength of its risk, institutional ownership, profitability, earnings, valuation, analyst recommendations and dividends.
Lucira Health（纳斯达克股票代码：LHDXQ — 获取评级）是 “诊断物质” 行业的41家上市公司之一，但与竞争对手相比，它的权重如何？我们将根据Lucira Health的风险实力、机构所有权、盈利能力、收益、估值、分析师建议和股息将Lucira Health与相关业务进行比较。
Profitability
盈利能力
This table compares Lucira Health and its competitors' net margins, return on equity and return on assets.
该表比较了Lucira Health及其竞争对手的净利润率、股本回报率和资产回报率。
| Net Margins | Return on Equity | Return on Assets | |
| Lucira Health | -67.54% | -13.55% | -8.47% |
| Lucira Health Competitors | -802.63% | -114.55% | -27.76% |
| 净利润 | 股本回报率 | 资产回报率 | |
| 露西拉健康 | -67.54% | -13.55% | -8.47% |
| 露西拉健康竞争对手 | -802.63% | -114.55% | -27.76% |
Valuation and Earnings
估值和收益
This table compares Lucira Health and its competitors gross revenue, earnings per share (EPS) and valuation.
该表比较了Lucira Health及其竞争对手的总收入、每股收益（EPS）和估值。
| Gross Revenue | Net Income | Price/Earnings Ratio | |
| Lucira Health | $93.06 million | -$64.83 million | -0.01 |
| Lucira Health Competitors | $486.78 million | $10.72 million | -53.52 |
| 总收入 | 净收入 | 市盈率 | |
| 露西拉健康 | 9306 万美元 | -6,483 万美元 | -0.01 |
| 露西拉健康竞争对手 | 4.8678 亿美元 | 1,072 万美元 | -53.52 |
Lucira Health's competitors have higher revenue and earnings than Lucira Health. Lucira Health is trading at a higher price-to-earnings ratio than its competitors, indicating that it is currently more expensive than other companies in its industry.
Lucira Health的竞争对手的收入和收益高于Lucira Health。Lucira Health的交易市盈率高于竞争对手，这表明它目前比业内其他公司更昂贵。
Analyst Recommendations
分析师建议
This is a breakdown of recent ratings and target prices for Lucira Health and its competitors, as provided by MarketBeat.com.
这是Marketbeat.com提供的Lucira Health及其竞争对手最近的评级和目标价格的明细。
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Lucira Health | 0 | 0 | 0 | 0 | N/A |
| Lucira Health Competitors | 372 | 632 | 1236 | 19 | 2.40 |
| 卖出评级 | 保持收视率 | 买入评级 | 强劲的买入评级 | 评分分数 | |
| 露西拉健康 | 0 | 0 | 0 | 0 | 不适用 |
| 露西拉健康竞争对手 | 372 | 632 | 1236 | 19 | 2.40 |
As a group, "Diagnostic substances" companies have a potential upside of 37.32%. Given Lucira Health's competitors higher possible upside, analysts clearly believe Lucira Health has less favorable growth aspects than its competitors.
作为一个整体，“诊断物质” 公司的潜在上涨空间为37.32％。鉴于Lucira Health的竞争对手可能有更大的上行空间，分析师显然认为Lucira Health的增长方面不如竞争对手。
Institutional and Insider Ownership
机构所有权和内部所有权
57.0% of Lucira Health shares are held by institutional investors. Comparatively, 46.6% of shares of all "Diagnostic substances" companies are held by institutional investors. 30.4% of Lucira Health shares are held by company insiders. Comparatively, 14.1% of shares of all "Diagnostic substances" companies are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.
Lucira Health的57.0％股票由机构投资者持有。相比之下，所有 “诊断物质” 公司的46.6％的股份由机构投资者持有。Lucira Health的股份中有30.4％由公司内部人士持有。相比之下，所有 “诊断物质” 公司的14.1％的股份由公司内部人士持有。强大的机构所有权表明捐赠基金、对冲基金和大型基金经理认为股票有望实现长期增长。
Volatility & Risk
波动性与风险
Lucira Health has a beta of 3.36, indicating that its stock price is 236% more volatile than the S&P 500. Comparatively, Lucira Health's competitors have a beta of 1.37, indicating that their average stock price is 37% more volatile than the S&P 500.
Lucira Health的beta值为3.36，这表明其股价的波动性比标准普尔500指数高236％。相比之下，Lucira Health的竞争对手的beta值为1.37，这表明他们的平均股价的波动性比标准普尔500指数高37％。
Summary
摘要
Lucira Health beats its competitors on 7 of the 10 factors compared.
在比较的10个因素中，Lucira Health在7个因素上击败了竞争对手。
About Lucira Health
关于 Lucira Health
(Get Rating)
（获取评分）
Lucira Health Inc. is a medical technology company. It is focused on the development and commercialization of transformative and infectious disease test kits. Lucira Health Inc. is based in Emeryville, California.
Lucira Health Inc. 是一家医疗技术公司。它专注于变革性和传染病检测试剂盒的开发和商业化。Lucira Health Inc. 总部位于加利福尼亚州的埃默里维尔。
Receive News & Ratings for Lucira Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lucira Health and related companies with MarketBeat.com's FREE daily email newsletter.
接收 Lucira Health Daily 的新闻和评级 -在下面输入您的电子邮件地址，即可通过Marketbeat.com的免费每日电子邮件时事通讯接收Lucira Health及相关公司的最新新闻和分析师评级的简明每日摘要。